DEN · Denbury Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $355.25M | $328.98M | $341.02M | - | $439.49M | $482.16M | $411.86M | - | $343.74M | $301.37M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $26.43M | $26.89M | $22.98M | - | $21.07M | $19.23M | $18.69M | - | $15.39M | $15.45M |
| Total Operating Expenses | $359.23M | $239.71M | $223.57M | - | $147.74M | $301.81M | $419.24M | - | $260.62M | $379.36M |
| D&A | $52.92M | $49.77M | $42.03M | - | $37.68M | $35.40M | $35.34M | - | $37.69M | $36.38M |
| Operating Income | ($3.98M) | $89.28M | $117.45M | - | $291.74M | $180.34M | ($7.38M) | - | $83.11M | ($77.99M) |
| Interest Expense | $843.0K | $825.0K | $927.0K | - | $909.0K | $1.53M | $657.0K | - | $669.0K | $1.25M |
| Income Tax | ($1.09M) | $22.00M | $28.25M | - | $41.32M | $24.85M | ($6.50M) | - | $403.0K | ($296.0K) |
| Net Income | ($2.89M) | $67.28M | $89.20M | - | $250.42M | $155.49M | ($872.0K) | - | $82.71M | ($77.69M) |
| EPS - Basic | ($0.06) | $1.30 | $1.73 | - | $4.89 | $3.00 | ($0.02) | - | $1.62 | ($1.52) |
| EPS - Diluted | ($0.06) | $1.25 | $1.66 | - | $4.66 | $2.83 | ($0.02) | - | $1.51 | ($1.52) |
Balance Sheet
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $803.0K | $531.0K | $525.0K | $521.0K | $519.0K | $517.0K | $517.0K | $3.67M | $1.78M | $13.56M |
| Accounts Receivable | $15.90M | $21.80M | $29.77M | $19.62M | $19.04M | $30.92M | $17.57M | $10.83M | $20.87M | $24.74M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | $58.91M | $61.64M | $53.01M | - | $25.70M | $38.58M | $27.17M |
| Current Assets | $194.30M | $210.68M | $212.14M | $206.23M | $249.65M | $282.10M | $244.42M | $175.41M | $177.89M | $191.06M |
| Total Assets | $2.65B | $2.54B | $2.43B | $2.33B | $2.24B | $2.14B | $2.03B | $1.90B | $1.81B | $1.75B |
| Current Liabilities | $376.40M | $296.73M | $298.95M | $346.86M | $386.59M | $539.20M | $529.13M | $406.68M | $495.30M | $493.60M |
| Long-term Debt | $70.34M | $85.15M | $68.28M | - | $15.00M | $0 | $35.00M | $35.00M | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $1.72B | $1.70B | $1.62B | $1.53B | $1.45B | $1.27B | $1.14B | $1.14B | $1.01B | $927.20M |
| Retained Earnings | $639.09M | $641.98M | $574.70M | $485.50M | $410.39M | $159.97M | $4.47M | $5.34M | ($115.29M) | ($198.00M) |
Cash Flow
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $88.52M | - | - | - | $90.14M | - | - | - |
| Investing Cash Flow | - | - | ($133.07M) | - | - | - | ($90.21M) | - | - | - |
| Financing Cash Flow | - | - | $44.62M | - | - | - | ($3.07M) | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -1.1% | 27.1% | 34.4% | - | 66.4% | 37.4% | -1.8% | - | 24.2% | -25.9% |
| EBITDA margin | 13.8% | 42.3% | 46.8% | - | 75.0% | 44.7% | 6.8% | - | 35.1% | -13.8% |
| Net margin | -0.8% | 20.5% | 26.2% | - | 57.0% | 32.2% | -0.2% | - | 24.1% | -25.8% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 7.4% | 8.2% | 6.7% | - | 4.8% | 4.0% | 4.5% | - | 4.5% | 5.1% |
| Effective tax rate | - | 24.6% | 24.1% | - | 14.2% | 13.8% | - | - | 0.5% | - |
| Return on assets | -0.1% | 2.6% | 3.7% | - | 11.2% | 7.3% | -0.0% | - | 4.6% | -4.4% |
| Return on equity | -0.2% | 4.0% | 5.5% | - | 17.2% | 12.3% | -0.1% | - | 8.2% | -8.4% |
| Return on invested capital | -0.2% | 3.8% | 5.3% | - | 17.1% | 12.3% | -0.5% | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.52 | 0.71 | 0.71 | 0.59 | 0.65 | 0.52 | 0.46 | 0.43 | 0.36 | 0.39 |
| Quick ratio | 0.52 | 0.71 | 0.71 | 0.59 | 0.65 | 0.52 | 0.46 | 0.43 | 0.36 | 0.39 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.03 |
| Leverage | ||||||||||
| Debt / Equity | 0.04 | 0.05 | 0.04 | - | 0.01 | 0.00 | 0.03 | 0.03 | - | - |
| Debt / Assets | 0.03 | 0.03 | 0.03 | - | 0.01 | 0.00 | 0.02 | 0.02 | - | - |
| Debt / EBITDA | 1.44 | 0.61 | 0.43 | - | 0.05 | 0.00 | 1.25 | - | - | - |
| Interest coverage | -4.7x | 108.2x | 126.7x | - | 321.0x | 118.2x | -11.2x | - | 124.2x | -62.3x |
| Equity multiplier | 1.55 | 1.49 | 1.50 | 1.52 | 1.54 | 1.69 | 1.79 | 1.68 | 1.79 | 1.89 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.13 | 0.13 | 0.14 | - | 0.20 | 0.23 | 0.20 | - | 0.19 | 0.17 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 16d | 24d | 32d | - | 16d | 23d | 16d | - | 22d | 30d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -19.2% | -31.8% | -17.2% | - | 27.9% | 60.0% | 64.0% | - | 102.2% | 155.7% |
| Revenue CAGR (3y) | 27.8% | 40.8% | 12.1% | - | 11.7% | 12.0% | 10.5% | - | -4.5% | -8.0% |
| Revenue CAGR (5y) | -2.1% | -3.2% | -0.7% | - | 10.5% | 13.0% | 8.4% | - | 6.2% | 3.4% |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | -50.5% | - | - | 251.0% | - | 89.4% | - | - | 90.2% |
| Net income growth (YoY) | - | -56.7% | - | - | 202.8% | - | 98.4% | - | - | 88.9% |
| EPS growth (YoY) | - | -55.8% | - | - | 208.6% | - | 98.6% | - | - | -7.8% |
| EPS CAGR (3y) | - | - | 128.0% | - | 221.7% | 106.8% | - | - | 107.1% | - |
| EPS CAGR (5y) | - | 78.0% | 79.1% | - | - | 134.4% | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 18.1% | 34.0% | 42.8% | 35.0% | 43.5% | 36.8% | 13.5% | 7.8% | -7.8% | 15.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2022-12-31.
Product / service
$3.28B totalOil And Gas$1.58B · 48.1%
Oil Reserves$1.56B · 47.5%
Oil Marketing$65.09M · 2.0%
Carbon Dioxide$60.57M · 1.8%
Natural Gas Reserves$19.57M · 0.6%
Peer comparison
Same SIC group: Crude Petroleum & Natural Gas
Comparing DENBURY INC against the 5 most active filers in the same SIC group.